New York Business Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New York Business Digest.

Press releases published on June 5, 2026

New York Car Service Addresses the $11.6 Billion Gap in Reliable Luxury Transportation Across New York State
Travelers Heading to the World Cup Can Save on Global eSIM Plans
B2i Digital Named Official Marketing Partner of 121 Mining Investment New York
Pyra AI Launches Lead Seeker, an AI-Powered Prospecting Workspace for Revenue Teams
Artefact Named Starburst’s 2026 Emerging Partner of the Year
Generated Awards Announces Winners of First-Ever AI Commercial Video Awards Show
Simply.Coach Earns 17 G2 Summer 2026 Badges, Marking Another Year of Recognition Across Coaching and Mentoring
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors it Has Filed a Complaint to Recover Losses Suffered by Purchasers of Verra Mobility Corporation Common Stock and Sets a Lead Plaintiff Deadline of August 4, 2026
NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials
Purecore Announces up to $1.5 Million Non-Brokered Private Placement
DentaQuest Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor…
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Global Aerospace's SM4 Aviation Safety Program Offers Essentials on Sleep Need vs. Sleep Capacity and The Science of Sleep Banking
Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth
A.I.S. Resources Announces Grant of Options
PFSI Investor News: If You Have Suffered Losses in PennyMac Financial Services, Inc. (NYSE: PFSI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New York Business Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.